RICHMAN ERIC I (Chief Executive Officer) purchased 6.2% of their position (17K shares) of GAIN THERAPEUTICS, INC. on the open market
Open‑market purchase worth $20.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 7/1/2024ACC: 0001493152-24-025831
Officer· Chief Executive Officer
Since Mar 2021
+17K
Net shares
Net buyer
$20.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
17K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$1.23
Trade value
$6.15K
% of position
1.8%
7/1/2024
272.63K→277.63K
Common Stock
Direct
Shares
+12K
Price / share
$1.21
Trade value
$14.52K
% of position
4.3%
7/1/2024
277.63K→289.63K
Total
Net shares
+17K
Net value
$20.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2024 | P · Purchase | +5K | $1.23 | $6.15K | 1.8% | 272.63K | 277.63K |
| Common Stock Direct | 7/1/2024 | P · Purchase | +12K | $1.21 | $14.52K | 4.3% | 277.63K | 289.63K |
| Total | +17K | $20.67K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned14.83K
Total
14.83K indirect14.83K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.83K | Indirect |
| Total | 14.83K | 14.83K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported